EUVIMED · CrossrefJournal
Helicobacter
ISSN 1083-4389 · Wiley
Latest articles
Issue Information
Efficacy and Safety of Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Regimens for First Line Helicobacter pylori Eradication—An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Lack of Usefulness of Literature‐Based Helicobacter pylori Resistance Data for Predicting First‐Line Empirical Treatment Effectiveness in the European Registry on H. pylori Management (Hp‐ EuReg )
Issue Information
Management Strategies for Helicobacter pylori —Application of the Stewardship Principles
Opportunistic Gastric Cancer Endoscopic Screening Integrated Into Population‐Based Colorectal Cancer Screening: A Retrospective Economic Cost‐Comparison Study
Population‐Level Trends in Gastric Cancer Mortality and Incidence After Expansion of Japanese National Health Insurance Coverage for Helicobacter pylori Eradication: A Descriptive Time‐Trend Study
Epidemiology of Helicobacter pylori and Gastric Atrophy in Rural Southwestern Uganda: The ENIGMA Uganda Study
A Novel Helicobacter pylori Test Based on 16S rRNA Isothermal Amplification Point‐of‐Care Testing of Throat Swab
Beyond Helicobacter pylori : Prevalence, Coinfection, and Clinicopathologic Patterns of Non‐ Helicobacter pylori Helicobacter (NHPH) in Human Gastric Biopsies
Intermediate OLGA / OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta‐Analysis
Antibiotic Resistance of Helicobacter pylori in Eastern China: An Updated Multicenter Cross‐Sectional Surveillance Study From 2022 to 2025
Efficacy of Standard Triple Therapy With or Without Statin in Helicobacter pylori Eradication: A Randomized Double‐Blind Placebo‐Controlled Trial
Diagnostic Accuracy of Serum Antibody, Urine Antibody, and Stool Antigen Tests for Helicobacter pylori in Japan: A Systematic Review and Meta‐Analysis
High Eradication Rate of a Potassium‐Competitive Acid Blocker‐Based Minocycline, Furazolidone, and Bismuth Regimen for Refractory Helicobacter pylori Infection: A Real‐World Study
Issue Information
A Bidirectional Association Between Helicobacter pylori Infection and Hyperlipidemia: Clinical Evidence and Mechanistic Insights
First Report of National Consensus Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Iran
Global Diversity of Helicobacter pylori Prophages Reveals Genetic Drivers of Virulence and Associations With Gastric Cancer
Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”
Efficacy and Safety of Fexuprazan‐Based Modified High‐Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial
Efficacy and Safety of Tegoprazan‐Based Dual, Triple, and Quadruple Therapies in First‐Line Helicobacter pylori Eradication: A Prospective Randomized Controlled Trial
Individuals and Family‐Screen‐to‐Treat‐Based Helicobacter pylori Eradication Strategy for Gastric Cancer Prevention: A Latin American Perspective
Real‐World Effectiveness and Safety of Saccharomyces boulardii CNCM I‐745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp‐ EuReg )
Susceptibility‐Guided Versus Empirical First‐Line Therapy of Helicobacter pylori Infection in Adults: A Systematic Review and Meta‐Analysis
Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predominantly Immigrant U.S. Population
Incidence of Gastric Cancer and Neuroendocrine Tumors in Autoimmune Gastritis: A Systematic Review and Meta‐Analysis of Follow‐Up Studies
Real‐Time Prediction of Helicobacter pylori Infection Using a Deep Learning Model During Esophagogastroduodenoscopy: A Prospective Multicenter Study
Helicobacter pylori Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of Treatment in Childhood
Prevalence of Autoimmune Gastritis Worldwide: A Systematic Review and Meta‐Analysis
EUVIMED